Viatris Pharma GmbH - Lenalidomid Viatris 15 mg, Hartkapseln | | 68557 | | 05 | | Lenalidomid Viatris 15 mg | | Hartkapseln | | L04AX04 | | Lenalidomide | | 04.04.2022 | | |
| Composition | lenalidomidum 15.0 mg, amylum pregelificatum, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, Kapselhülle: titanii dioxidum, gelatina, Drucktinte: lacca, E 172 (rubrum), propylenglycolum, simeticonum, pro capsula corresp. natrium 0.986 mg. | Packungsbestandteile | | Capsules | | | | | | Active Agent | Dose |
---|
Lenalidomidum | 15 mg |
| BAG: Active Agent | Dose |
---|
Lenalidomidum | 15 mg |
| | Inactive agents | | additional_information |
---|
(Rubrum) | | | Amylum Pregelificatum | | | Carmellosum Natricum Conexum | | | Cellulosum Microcristallinum | | | E 172 | | color. | Gelatina | | | Lacca | | Drucktinte | Natrii Stearylis Fumaras | | | Propylenglycol | | | Silica Colloidalis Anhydrica | | | Simeticone | | | Titanium Dioxide | | Kapselhülle |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
005 | 21 | 782.79 | 867.75 | A | SL | Yes |
|
|